BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/21/2025 8:36:45 AM | Browse: 15 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 105264
Country China
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Nav1.6 drives colorectal cancer proliferation and invasion through MAPK signaling pathway
Manuscript Source Unsolicited Manuscript
All Author List Li-Ming Zhao, Wan-Ying Hong, Jian-Guang Xu, Shui-Quan Lin, Ming-Sheng Liu, Li-Hui Wang, Xu-Li Jiang, Ming Sang and Yang-Bo Lv
Funding Agency and Grant Number
Funding Agency Grant Number
Science and Technology Project of Quzhou of China 2021Y011
Beijing Science and Technology Innovation Medical Development Foundation KC2021-JX-0186-81
Corresponding Author Yang-Bo Lv, Department of Colorectal Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, No. 100 Minjiang Avenue, Quzhou 324002, Zhejiang Province, China. lyb20110115@163.com
Key Words Nav1.6; Colorectal cancer; Weighted correlation network analysis; MAPK signaling; Cancer proliferation
Core Tip Voltage-gated sodium channels are prominently expressed in various tumors and play a crucial role in tumor metastasis and invasion. Our research identified 575 differentially expressed genes related to Nav1.6 in colorectal cancer (CRC), particularly enriched in MAPK signaling pathways. Tissue microarray revealed heightened Nav1.6 levels in CRC tissues. The cytoplasmic expression of Nav1.6 increases with T staging. Knockdown of SCN8A in colon tumor cells significantly decreased cell proliferation and invasion, along with downregulation of key proteins in the RAF-MAPK pathway. These findings suggest that Nav1.6 enhances CRC cell proliferation and invasion through modulation of the MAPK signaling pathway.
Citation Zhao LM, Hong WY, Xu JG, Lin SQ, Liu MS, Wang LH, Jiang XL, Sang M, Lv YB. Nav1.6 drives colorectal cancer proliferation and invasion through MAPK signaling pathway. World J Gastrointest Oncol 2025; In press
Received
2025-01-18 06:51
Peer-Review Started
2025-01-18 06:51
To Make the First Decision
Return for Revision
2025-02-26 07:42
Revised
2025-03-12 07:45
Second Decision
2025-04-21 02:36
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-04-21 08:36
Articles in Press
2025-04-21 08:36
Publication Fee Transferred
2025-03-13 05:45
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com